293 results on '"Salas, Maribel"'
Search Results
2. Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy
3. Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review
4. The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature
5. Health-related quality of life in women with breast cancer: a review of measures
6. Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week
7. Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities
8. Review of survival, safety, and clinical outcomes in HER2+ metastatic gastric cancer following the administration of trastuzumabPost-Trastuzumab Gastric Cancer
9. Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA
10. The American Program in Pharmacovigilance (Am2P): a new accredited online training program in pharmacovigilance and pharmacoepidemiology
11. Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review
12. An Update of the North American Chapter of the International Society of Pharmacovigilance (NASoP)
13. A Retrospective Study of Comorbidities and Complications in Elderly Acute Myeloid Leukemia Patients in the United States
14. Real-world treatment patterns, healthcare resource utilization and costs among patients with peripheral T-cell lymphoma.
15. Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework.
16. Real-world treatment patterns, healthcare resource utilization and costs among patients with peripheral T-cell lymphoma
17. Discrepancies in ICD-9/ICD-10-based codes used to identify three common diseases in cancer patients in real-world settings and their implications for disease classification in breast cancer patients and patients without cancer: a literature review and descriptive study
18. Real world data for rare diseases research: The beginner’s guide to registries
19. PB2303: REAL-WORLD TREATMENT PATTERNS AND ADVERSE EVENTS AMONG PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA: A RETROSPECTIVE DATABASE STUDY
20. Use of Real‐World Evidence in a Virtual Bridging Analysis for a Human Epidermal Growth Factor Receptor 2–Targeted Antibody–Drug Conjugate in Gastric Cancer
21. Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia
22. Abstract 6754: Clinical characteristics, real-world treatment patterns, and clinical outcomes among patients with previously treated metastatic or unresectable EGFR-mutated non-small cell lung cancer in the United States
23. Abstract P4-07-53: Adverse events (AEs) in phase III clinical trials of patients with human epidermal growth factor receptor-2 positive (HER2+) breast cancer (BC): a meta-analysis
24. Phase 4 (Postmarketing) Research
25. Research Methods for Pharmacoepidemiology Studies
26. Drug utilization research in Peru: Is real-world data available?
27. The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
28. Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiology and End Results-Medicare database
29. Incidence and risk factors for development of cardiac toxicity in adult patients with newly diagnosed acute myeloid leukemia
30. sj-docx-1-bmi-10.1177_11772719231164528 – Supplemental material for The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
31. Elderly patients with acute myeloid leukemia who only receive supportive care in the Surveillance, Epidemiology and End Results-Medicare database: demographics, treatment patterns and outcomes.
32. Editorial: Leveraging pharmacovigilance data mining with “the patient” in mind
33. Methods used to generate safety-related evidence in real-world oncology settings: A systematic literature review.
34. Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest Group
35. Data sources for drug utilization research in Latin American countries-A cross-national study: DASDUR-LATAM study
36. Turalio risk evaluation and mitigation strategy for treatment of tenosynovial giant cell tumor: framework and experience
37. Data sources for drug utilization research in Latin American countries—A cross‐national study: DASDUR‐LATAM study
38. Safety surveillance and challenges in accelerated COVID-19 vaccine development
39. Costs of Medication Nonadherence in Patients with Diabetes Mellitus: A Systematic Review and Critical Analysis of the Literature
40. Evaluation of patient/caregiver and healthcare provider knowledge, attitudes and behavior for safety and use of pexidartinib
41. Use of comorbidity indices in patients with any cancer, breast cancer, and human epidermal growth factor receptor-2-positive breast cancer: A systematic review
42. Transparencia de datos para construir un sistema de salud más sólido: estudio de caso de bases de datos administrativas argentinas sobre utilización de medicamentos
43. Additional file 1 of Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review
44. El modelo pedagógico constructivista en la atención a la diversidad
45. Data transparency for building a stronger healthcare system: A case study from Argentinean administrative drug utilization data sources
46. Health-related quality of life in women with breast cancer: A review of measures
47. Analysis of US Food and Drug Administration Warning Letters: False Promotional Claims Relating to Prescription and Over-the-Counter Medications
48. Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study
49. An Examination of State and Federal Opioid Analgesic and Continuing Education Policies: 2016–2018
50. Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.